References
- Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1–36
- Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal infections and prematurity study group. Obstet Gynecol 1991;77:604–10
- Baltimore RS, Huie SM, Meek JI, et al. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094–8
- Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663–70
- Mercer BM, Arheart KL. Antibiotic therapy for preterm premature rupture of the membranes. Semin Perinatol 1996;20:426–38
- Garland SM, Kelly N, Ugoni AM. Is antenatal group B streptococcal carriage a predictor of adverse obstetric outcome? Infect Dis Obstet Gynecol 2000;8:138–42
- Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2010;8:CD001058
- Lovett SM, Weiss JD, Diogo MJ, et al. A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997;176:1030–8
- Lewis DF, Adair CD, Robichaux AG, et al. Antibiotic therapy in preterm premature rupture of membranes: are seven days necessary? A preliminary, randomized clinical trial. Am J Obstet Gynecol 2003;188:1413–6; discussion 16–7
- Segel SY, Miles AM, Clothier B, et al. Duration of antibiotic therapy after preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2003;189:799–802
- Ehsanipoor RM, Chung JH, Clock CA, et al. A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol 2008;198:e54–6
- Hutzal CE, Boyle EM, Kenyon SL, et al. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a metaanalysis. Am J Obstet Gynecol 2008;199:620. e1–8
- Melamed N, Hadar E, Ben-Haroush A, et al. Factors affecting the duration of the latency period in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2009;22:1051–6
- Mercer BM. Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am 2005;32:411–28
- Cape A, Tuomala R, Tylor C, Puopolo K. Peripartum bacteremia in the era of GBS prophylaxis. Obstet Gynecol 2013;121:812–6